XML 79 R69.htm IDEA: XBRL DOCUMENT v3.23.3
COMMITMENTS AND CONTINGENCIES (Details)
$ in Thousands
Oct. 23, 2023
USD ($)
installment
Aug. 03, 2023
USD ($)
Dec. 21, 2020
patent
Sep. 30, 2023
USD ($)
Sep. 07, 2023
USD ($)
Dec. 31, 2022
USD ($)
Loss Contingencies [Line Items]            
Legal charges pending settlement       $ 62,800   $ 0
Myriad Genetics, Inc. Securities Litigation            
Loss Contingencies [Line Items]            
Settlement agreement   $ 77,500        
Litigation settlement, amount awarded to other party, cash   20,000     $ 20,000  
Litigation settlement, amount awarded to other party, common stock   57,500        
Litigation settlement, amount awarded to other party, elected payment   $ 57,500        
Litigation settlement, period to determine awarded common stock   10 days        
Litigation settlement, number of outstanding shares, common stock   5.00%        
Myriad Genetics, Inc. Securities Litigation | Pending Litigation            
Loss Contingencies [Line Items]            
Legal charges pending settlement       57,500    
Raygen, Inc vs. Myriad Women's Health, Inc.            
Loss Contingencies [Line Items]            
Number of patents allegedly infringed | patent     2      
Accrual       34,000    
Accrual, noncurrent       29,000    
Accrual, current       $ 5,000    
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Contingent Payments | Subsequent Event            
Loss Contingencies [Line Items]            
Settlement agreement $ 21,250          
Number of annual installments | installment 5          
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Contingent Payments | Subsequent Event | First Installment            
Loss Contingencies [Line Items]            
Settlement agreement $ 5,000          
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Contingent Payments | Subsequent Event | Second Installment            
Loss Contingencies [Line Items]            
Settlement agreement 5,000          
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Contingent Payments | Subsequent Event | Third Installment            
Loss Contingencies [Line Items]            
Settlement agreement 5,000          
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Contingent Payments | Subsequent Event | Fourth Installment            
Loss Contingencies [Line Items]            
Settlement agreement 5,000          
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Contingent Payments | Subsequent Event | Final Installment            
Loss Contingencies [Line Items]            
Settlement agreement 1,250          
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Non-Contingent Payments | Subsequent Event            
Loss Contingencies [Line Items]            
Settlement agreement $ 12,750          
Number of annual installments | installment 3          
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Non-Contingent Payments | Subsequent Event | First Installment            
Loss Contingencies [Line Items]            
Settlement agreement $ 5,000          
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Non-Contingent Payments | Subsequent Event | Second Installment            
Loss Contingencies [Line Items]            
Settlement agreement 5,000          
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Non-Contingent Payments | Subsequent Event | Third Installment            
Loss Contingencies [Line Items]            
Settlement agreement $ 2,750